Experience | Leaflets | Patient+ | Guidelines | Weblinks | News | Products | Other
This is a PatientPlus article. PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.
Influenza
Synonym: Flu
Acute respiratory illness due to infection with the influenza virus. There are three serotypes: A, B and C. Influenza A & B viruses cause most clinical disease.
- A is the more frequent and the cause of major influenza outbreaks.
- B tends to circulate with A in yearly outbreaks and causes less severe illness.
- C tends to cause a mild or asymptomatic illness akin to the common cold.
Influenza A serotypes are further categorised by their surface antigens:
- H: haemagglutinin - facilitates entry of virus into host respiratory cell
- N: neuraminidase - facilitates release of virions from infected host cells
There are 15 H and 9 N subtypes of the A virus in aquatic birds, who together with pigs (often termed the "mixing vessel" for scrambling human and avian virus genetic material) are the natural reservoir of the virus.
The influenza virus undergoes minor mutations to one or both of its surface antigens - antigenic drift. This causes seasonal epidemics where people have only partial immunity from previous infection. In influenza A alone, major and sudden changes in the H and N antigens produces a new virus sub-type - antigenic shift. There is little population immunity to the new form and a major epidemic may ensue.
There is evidence emerging that humans can serve as the "mixing vessel" for at least some of the 15 avian subtypes circulating in bird populations.
Incidence
Cases peak in:
- December to March in temperate regions of Northern hemisphere
- May to September in Southern hemisphere
- Cases throughout the year in tropical areas
Up to 15% of the population can develop influenza in any year. There is a 10-20% seroconversion rate with or without symptoms.
In an average year, there are 50-200 GP consultations for influenza, or flu-like illnesses, per 100,000 population per week.1
It is highly infectious with a ratio of infections:clinical cases of between 3:1 and 9:1.
An epidemic can be declared when GP consultation rate for new cases of influenza or flu-like illness is >400/100,000 population/week. This occurred in UK in 1989/90, partial outbreak and Northern European epidemic in 2003.
Rarely, there are pandemics. There have been 3 in the last 100 years. Their effects can be devastating; the 1918 outbreak killed around 21 million worldwide.2 That is 6x more casualties than The Great War.
Risk Factors
- Closed environments e.g. residential homes, schools and prisons
- Advanced age
- Pre-existing cardiac or respiratory illness
Transmission is usually by droplet due to coughing/sneezing; direct nasal or eye contact with hands carrying virus can also produce infection. After incubation period of around 2 days patient commonly presents with rapid onset of:
- Anorexia
- Malaise
- Headache (retro-orbital)
- Fever
- Myalgia
- Non-productive cough and sore throat
Nasal discharge/obstruction and sneezing can occur but are not usually prominent features of the illness.2
The symptoms typically last for 3-5 days but cough, tiredness and malaise may last for 1-2 weeks.
Infectivity continues for 5 days from onset, though children can remain infectious for 2 weeks, and the severely immunocompromised can shed virus for weeks.
Neonates and infants may present with lethargy, poor feeding, apnoea or fever, pneumonia or otitis media.
Drowsiness occurs in 50% children aged <4 years, and in around 10% aged 4-15 years. It is uncommon in adults.
Fever may not be seen in older patients.
Gastrointestinal symptoms are not usual but may occur in a minority of patients.
There are many, the most important being listed below:
- Common cold/upper respiratory tract infection caused by multitude of viruses
- Pharyngitis - multiple aetiologies
- Meningitis
- Bacterial or viral pneumonia/lower respiratory tract infection
- Malaria or dengue fever in returning travellers
- Infectious mononucleosis
- Cytomegalovirus
- Acute HIV seroconversion illness
The diagnosis is a clinical one so investigations are usually reserved for community surveillance purposes. Available tests include:
- Direct viral culture of nasopharyngeal swabs/aspirates
- Immunofluorescence of nasopharyngeal swabs/aspirates
- Acute and convalescent sera, 10-14 days apart
- Polymerase chain reaction
- Rapid bedside antigen tests (not wholly reliable)
Non-Drug
In otherwise healthy individuals with uncomplicated illness, self-management is recommended including rest, increased fluid intake, analgesics and antipyretics. Aspirin should be avoided in children <12 years due to the danger of Reye's syndrome.
Drugs
Three antiviral drugs are licensed for the treatment of influenza:
- Zanamivir3; a neuraminidase inhibitor, licensed for treatment of influenza A & B in patients age >12 years when given within 48 hours of onset of symptoms and influenza is circulating.
- Oseltamivir4; also a neuraminidase inhibitor like zanamivir active against all strains of A & B viruses, licensed in patients aged >1 year with same conditions as zanamivir. Also licensed for prophylaxis in patients age >13 years. Cochrane recommends the use of neuraminidase inhibitors is restricted to epidemics and pandemics.5
- Amantadine6; (and related Rimantadine) thought to work by blocking cellular membrane ion channels, are only active against influenza A viruses. Although licensed for treatment of and prophylaxis against influenza A in patients at risk of complications, it has low rates of effectiveness7 and NICE does not recommend it's use.8 Should also be started within 48 hours of symptoms.
All three above have been shown to reduce duration of symptoms by approx. 1 day. Their role in reducing the incidence of complications is less clear and heavily dependent on the patient group taking the drug.
NICE recommends the use of zanamivir and oseltamivir for the treatment of at-risk adults who fulfil the above conditions.8 At-risk patients include those with:
- Chronic respiratory disease, including asthma
- Chronic heart disease, excluding uncomplicated, controlled hypertension
- Chronic renal disease
- Diabetes mellitus
- Immunosuppression - including asplenia or splenic dysfunction, or have received systemic steroids equivalent to 20mg prednisolone daily for more than 2 weeks.
Oseltamivir is licensed in some countries for use as a prophylactic agent against infection after exposure in non-immunised individuals. NICE recommends oseltamivir for post-exposure prophylaxis in people who are11:
- Aged 13 years and older
- At-risk
- Not effectively protected by vaccination
- In very close contact (i.e. someone who lives in the same house as a person suffering from symptoms of flu-like illness
- Able to begin prophylaxis within 48 hours of exposure
Oseltamivir is therefore available on an NHS prescription for post-exposure prophylaxis under these circumstances, and the prescription must be endorsed 'SLS'. NICE do not recommend use of oseltamivir for seasonal prophylaxis of influenza (prescribing for a period of 6 weeks or so when the virus is circulating in the community).
In the event of a new pandemic strain emerging, new guidance on prophylaxis is expected.
Respiratory complication include:
- Acute bronchitis (about 20% cases with increased risk in the elderly and those with chronic disease)
- Secondary bacterial pneumonia (especially Staph. aureus)
- Primary viral pneumonia
- Exacerbations of asthma and COPD
- Empyema
- Pulmonary aspergillosis
- Sinusitis
Non-respiratory complications include:
- Febrile convulsions
- Otitis media
- Toxic shock syndrome
- Myositis and myoglobinaemia
- Heart failure
- Myocarditis
- Reye's syndrome
- Guillain-Barré syndrome
- Transverse myelitis
- Encephalitis
Risk of complications with hospitalisation and death are higher among:
- Those age >65 years
- Very young children
- Those with at risk factors shown above
Residents of nursing homes are particularly at risk of serious complications because of their age, high rate of chronic disease and living in a closed community.
In pregnant women there is a slight increase in perinatal mortality rate as well as early and late fetal deaths.
Each year 3-4,000 deaths are attributed to influenza in the UK.
During epidemics, can be much higher, e.g. 30,000 excess deaths in 1989-90 with 89% of these being in people aged over 65 years.12
Document references
- Influenza, Clinical Knowledge Summaries (2006)
- Derlet R, Lawrence R; Influenza.; e-Medicine; January 2007
- Hoffken G, Gillissen A; Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors. Med Microbiol Immunol. 2002 Dec;191(3-4):169-73. Epub 2002 Sep 11. [abstract]
- Li L, Cai B, Wang M, et al; A double-blind, randomized, placebo-controlled multicenter study of oseltamivir phosphate for treatment of influenza infection in China. Chin Med J (Engl). 2003 Jan;116(1):44-8. [abstract]
- Mayor S; Review says oseltamivir and zanamivir should be kept for epidemics of flu.; BMJ. 2006 Jan 28;332(7535):196.
- Jefferson T, Demicheli V, Di Pietrantonj C, et al; Amantadine and rimantadine for influenza A in adults. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD001169. [abstract]
- Jefferson T, Demicheli V, Rivetti D, et al; Antivirals for influenza in healthy adults: systematic review. Lancet. 2006 Jan 28;367(9507):303-13. [abstract]
- Flu Treatment - zanamivir (review), amantadine and oseltamivir, NICE (2003); Ref TA58
- Colman PM; Zanamivir: an influenza virus neuraminidase inhibitor. Expert Rev Anti Infect Ther. 2005 Apr;3(2):191-9. [abstract]
- Wutzler P, Kossow KD, Lode H, et al; Antiviral treatment and prophylaxis of influenza in primary care: German recommendations. J Clin Virol. 2004 Oct;31(2):84-91. [abstract]
- Flu Prevention - amantadine and oseltamivir, NICE (2003); The clinical effectiveness and cost effectiveness of amantadine and oseltamivir for the prophylaxis of influenza. Ref TA67
- Donaldson GC, Keatinge WR; Excess winter mortality: influenza or cold stress? Observational study. BMJ. 2002 Jan 12;324(7329):89-90.
Internet and further reading
- Influenza immunisation, Clinical Knowledge Summaries (2006)
- Pandemic flu: Clinical management of patients with an influenza-like illness during an influenza pandemic, Provisional guidelines from the British Infection Society British Thoracic Society Health Protection Agency in collaboration with the Department of Health (2007)
- Flu key documents; Department of Health. Accessed 2007; Flu documents and resources for patients and health professionals. Includes frequently asked questions, anti-viral agent information, contingency plans and immunisation publicity campaigns.
DocID: 2323
Document Version: 22
DocRef: bgp372
Last Updated: 19 Oct 2007
Review Date: 18 Oct 2009
The authors and editors of this article are employed to create accurate and up to date content reflecting reliable research evidence, guidance and best clinical practice. They are free from any commercial conflicts of interest.
Find out more about updating.
Related pages in Patient UK
Your Experience (^ top of page)
Please add your experience about this condition / medicine
View Patient Experience for 'Influenza' (7 there)Health Topic information leaflets related to this topic (^ top of page)
Flu Like Illness
Influenza Immunisation
Preventing Flu
Swine FluPatientPlus articles related to this topic (^ top of page)
Antivirals for Influenza
Influenza Vaccination
Swine FluUK guidelines related to this topic (^ top of page)
Guidelines on FluLinks to other selected websites related to this topic (^ top of page)
InfluenzaPatient UK Newspaper (^ top of page)
Recent related news items
Britons 'ignoring advice on swine flu'
Harry Potter and the Deathly Swine Flu: Ron Weasley actor is first celebrity victim of bug
First swine flu death in London - BBC News
New Zealand confirms H1N1 deaths
Chief doctor warns public not to buy Tamiflu on the internetAll news by related topic
Flu news
Influenza Virus Vaccine news
Swine Flu newsRelated Products (^ top of page)
Patient UK Pharmacy
Actifed Multi-Action Tablets
Anadin Extra Tablets
Anadin Tablets
Anadin Ultra Ibuprofen Capsules
Aspro Clear Tablets
Beechams Active Cold Relief Caplets
Beechams All In One Tablets
Beechams All-In-One cl
Beechams Cold + Flu Lemon
Beechams Decongestant Plus With Paracetamol
Beechams Flu Plus Hot Berry Fruits
Beechams Flu Plus Hot Lemon
Beechams Flu-Plus Caplets
Beechams Powders
Benylin Cold & Flu Day & Night Max Strength Capsules
Benylin Cold and Flu Max Strength Capsules
Benylin Cold and Flu Max Strength Lemon Sachets
Benylin Four Flu Tablets
CalCold
Calpol Night
Codis 500 Tablets
Contac Non Drowsy 12 Hour Relief
Lemsip Cold & Flu Original Lemon
Lemsip Max All In One Breath Easy
Lemsip Max All in One Liquid
Lemsip Max Cold & Flu Capsules
Lemsip Max Cold & Flu Direct Lemon
Lemsip Max Cold & Flu Lemon Hot Drink
Lemsip Max Day and Night Cold and Flu Relief Capsules
Lemsip Max Flu Lemon - Pharmacy Formulation
NeilMed Sinse Rinse Refill Sachets
NeilMed Sinus Rinse Kit
NeilMed Sinus Rinse Pediatric Kit
Nurofen Express Double Strength Liquid Capsules 400mg
Nurofen Tablets
Olbas Powerflu
Orbifen Cold & Flu Oral Suspension
Panadol Advance
Paracodol Soluble Tablets
Propain Caplets
Propain Plus Caplets
Sinutab
Solpadeine Capsules
Solpadeine Max Tablets
Solpadeine Plus Soluble Tablets
Solpadeine Plus Tablets
Solpaflex Tablets Cl
Sudafed Congestion, Cold and Flu Tablets
Sudafed Day & Night Capsules
Sudafed Non Drowsy Childrens Syrup
Veganin Tablets
Vicks Inhaler
Vicks Sinex Decongestant Capsules
Voltarol Pain-eze TabletsMedical equipment

Books

Other - Useful resources (^ top of page)
Pictures, diagrams, photos, images, etc.Evidence based medicine
Online textbooks and journals
UK Guidelines
Online Videos
Medline
Other good health sites
Disclaimer: Patient UK has no control over the content of any external links above. Inclusion does not imply endorsement by Patient UK.
Want to advertise on this site? Find out how >>
Here you can follow a link to view existing patient experiences on this subject, or to add your own
This will offer you the usual PDF options i.e. document navigation, search, zoom and formatted print
Note: this is the best way to print the document
Note: this will open in a new window
Note: this will open in a new window







